Results 121 to 130 of about 29,283 (148)

Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrel. [PDF]

Open Heart
Pareek A, Chandurkar N, Raut V, Naidu K.
europepmc   +1 more source

A new naphthalene-based fluorogenic substrate for cytochrome P450 4A11. [PDF]

Biochem J
Davydov DR, Ponraj K, Davydova N, Singh DK, Prasad B.   +4 more
europepmc   +1 more source

CYP2C19 loss-of-function variants are independent risk factors for premature cerebral infarction: a hospital based retrospective study. [PDF]

BMC Cardiovasc Disord
Shi Y, Yang Y, Feng M, Wu H.
europepmc   +1 more source

Valproic acid levels in neurodevelopmental disorders: correlation with CYP and SULT genes using LC-MS/MS. [PDF]

BMC Neurol
Abutaleb S, Mallah E, Abu-Qatouseh L, Abu-Awwad A, Mansoor K, Khallad S, Omari KW, Mouhtady O, Arafat T.   +8 more
europepmc   +1 more source

Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder. [PDF]

BMC Psychiatry
Jarčušková D, Tkáč I, Hlaváčová N, Yaluri AS, Kozárová M, Habalová V, Klimčáková L, Židzik J, Javorský M, Bednářová A.   +9 more
europepmc   +1 more source

Employing Automated Machine Learning (AutoML) Methods to Facilitate the <i>In Silico</i> ADMET Properties Prediction. [PDF]

J Chem Inf Model
Han H, Shaker B, Lee JH, Choi S, Yoon S, Singh M, Basith S, Cui M, Ahn S, An J, Kang S, Yeom MS, Choi S.   +12 more
europepmc   +1 more source

Improving CYP2C19 phenotyping using stereoselective omeprazole and 5-hydroxy-omeprazole metabolic ratios. [PDF]

Basic Clin Pharmacol Toxicol
Abouir K, Varesio E, Déglon J, Samer C, Daali Y.   +4 more
europepmc   +1 more source

Typical and atypical metabolic characteristics of three iridaceae isoflavone components: in vitro and in silico studies. [PDF]

Front Pharmacol
Gu J, Zhang H, Wang M, Zhou Y, Deng Z, Shi R.   +5 more
europepmc   +1 more source

Examining the Impact of Diet-and-Exercise-Induced Weight Loss on Drug Metabolism and Gastric Emptying in Patients with Obesity. [PDF]

J Clin Pharmacol
Liu S, Wang L, Miller N, Waltje A, Abdelnabi M, Zhu HJ, Sun D, Rothberg AE, Pai MP.   +8 more
europepmc   +1 more source

Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights. [PDF]

Clin Pharmacokinet
Saleh A, Schulz J, Schlender JF, Aulin LBS, Konrad AP, Kluwe F, Mikus G, Huisinga W, Kloft C, Michelet R.   +9 more
europepmc   +1 more source